BridgeMD
New treatment option for Schizophrenia
Official title Song-making In a Group (SING)
ClinicalTrials.gov ID: NCT05929352
What this study is testing
- What it's testing
- The overarching aim of the proposed work is to align a promising treatment lead - Musical Intervention (MI) - with a promising mechanistic account of psychosis - Predictive Processing. This protocol focuses on the R33 phase, to optimize its administration (Is active participation more effective than passive listening?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- voice hearing patients meeting diagnostic criteria for Diagnostic and Statistical Manual-V psychotic disorder
- hearing voices at least once a day
- PANSS P3 (Hallucinations item) greater than 3
- Prior to study participation all patients will be evaluated for i) protocol eligibility; ii) ability to give informed consent; iii) interaction with...
You likely can't join if
- Diagnostic and Statistical Manual-IV substance abuse or dependence (past six months)
- clinically significant medical conditions, head injury with neurological symptoms or unconsciousness
- mental retardation (IQ\<70)
- Non-English speaking
- no less than 2 weeks of stable doses of psychotropic medications (to avoid transient effects of medication regiment change; medication type and dose...
- Co-morbid mood or anxiety diagnosis
See the full eligibility criteria
- voice hearing patients meeting diagnostic criteria for Diagnostic and Statistical Manual-V psychotic disorder
- hearing voices at least once a day
- PANSS P3 (Hallucinations item) greater than 3
- Prior to study participation all patients will be evaluated for i) protocol eligibility; ii) ability to give informed consent; iii) interaction with the study team to determine participant's probability of completing...
- Diagnostic and Statistical Manual-IV substance abuse or dependence (past six months)
- clinically significant medical conditions, head injury with neurological symptoms or unconsciousness
- mental retardation (IQ\<70)
- Non-English speaking
- no less than 2 weeks of stable doses of psychotropic medications (to avoid transient effects of medication regiment change; medication type and dose will be carefully recorded and used as a covariate in all analyses)
- Co-morbid mood or anxiety diagnosis
- clinically/behaviorally unstable and unable to cooperate with SING procedures
- Unstable medical condition based on medical history, physical examination and routine laboratory work-up
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.